Nations Financial Group’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Nations Financial Group’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-6,849	Closed	-$792K	–	653
2023 Q3	$792K	Hold	6,849	–	–	0.08%	265
2023 Q2	$704K	Sell	6,849 -4,030	-37%	-$425K	0.07%	294
2023 Q1	$1.19M	Buy	10,879 +1,850	+20%	+$204K	0.12%	196
2022 Q4	$1.03M	Sell	9,029 -3,000	-25%	-$249K	0.12%	218
2022 Q3	$744K	Sell	12,029 -1,214	-9%	-$84.8K	0.11%	210
2022 Q2	$1.06M	Buy	13,243 +4,303	+48%	+$407K	0.14%	184
2022 Q1	$941K	Buy	8,940 +2,703	+43%	+$263K	0.11%	199
2021 Q4	$672K	Buy	6,237 +985	+19%	+$107K	0.09%	235
2021 Q3	$575K	Buy	+5,252	New	+$545K	0.09%	246

Other funds holding HZNP

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Blue Trust Inc Alpharetta, Georgia $9.51B AUM 13.02% 1-Year Est. Return

VWA

Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return

FSWA

Financial Synergies Wealth Advisors Houston, Texas $1.22B AUM 22.8% 1-Year Est. Return

BCMLT

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Nations Financial Group's HZNP Position: Q4 2023 in Review

Nations Financial Group sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 6,849 shares — an estimated $792K sold.

Nations Financial Group first reported a position in HZNP in Q3 2021 and held it in 9 quarters. The position peaked at $1.19M in Q1 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

Nations Financial Group reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
Nations Financial Group sold 6,849 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $792K.
Nations Financial Group first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2021 and held it in 9 quarters.
Nations Financial Group's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $1.19M in Q1 2023.
6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Nations Financial Group's 13F filing for Q4 2023, filed 9 Feb 2024.